(1)
Nour-Eddine Ziraoui; Sofia Rossi; Volkov, D. Clinical Evaluation of a Time-Sequential Biphasic NMN–Resveratrol–Quercetin–Piperine NAD+ Supplement Targeting SIRT1 (BCLC™). FSD 2026, 6 (4), 1-9. https://doi.org/10.54691/7pt02z87.